These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34715652)

  • 1. Multiple predictors of in-stent restenosis after stent implantation in symptomatic intracranial atherosclerotic stenosis.
    Yu Y; Yan L; Lou Y; Cui R; Kang K; Jiang L; Mo D; Gao F; Wang Y; Lou X; Miao Z; Ma N
    J Neurosurg; 2022 Jun; 136(6):1716-1725. PubMed ID: 34715652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China.
    Guo X; Ma N; Gao F; Mo DP; Luo G; Miao ZR
    Front Neurol; 2020; 11():601199. PubMed ID: 33574792
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood biomarkers of progressive atherosclerosis and restenosis after stenting of symptomatic intracranial artery stenosis.
    Haidegger M; Kneihsl M; Niederkorn K; Deutschmann H; Mangge H; Vetta C; Augustin M; Wünsch G; Fandler-Höfler S; Horner S; Enzinger C; Gattringer T
    Sci Rep; 2021 Aug; 11(1):15599. PubMed ID: 34341413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying risk factors for in-stent restenosis in symptomatic intracranial atherosclerotic stenosis: a systematic review and meta-analysis.
    Wang N; Lu Y; Feng L; Lin D; Gao Y; Wu J; Wang M; Wan S
    Front Neurol; 2023; 14():1170110. PubMed ID: 37521300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Drug-Eluting Stent With Bare-Metal Stent in Patients With Symptomatic High-grade Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial.
    Jia B; Zhang X; Ma N; Mo D; Gao F; Sun X; Song L; Liu L; Deng Y; Xu X; Zhang Y; Liu Z; Guan S; Zhang F; Li B; Zheng H; Liu X; Liu Y; Chen K; Shuai J; Wan J; Wang J; Shi X; Li T; Chang B; Liebeskind DS; Yu W; Miao Z;
    JAMA Neurol; 2022 Feb; 79(2):176-184. PubMed ID: 34982098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual inflammatory risk predicts long-term outcomes following stenting for symptomatic intracranial atherosclerotic stenosis.
    Yu Y; Lou Y; Pan Y; Yan L; Fu W; Hou Z; Cui R; Miao Z; Wang Y; Lou X; Ma N
    Stroke Vasc Neurol; 2024 Aug; 9(4):407-417. PubMed ID: 37640497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C associates with the prediction of in-stent restenosis among patients receiving stent implantation: results of the 1-year follow-up.
    Zhao C; Yang L; Mao L; Zhong L; Li X; Wei S
    Coron Artery Dis; 2013 Aug; 24(5):357-60. PubMed ID: 23835667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of plasma C-reactive protein in predicting in-stent restenosis in patients with stable angina after coronary stenting.
    Xu YL; Li JJ; Xu B; Zhu CG; Yang YJ; Chen JL; Qiao SB; Yuan JQ; Qin XW; Ma WH; Yao M; Liu HB; Wu YJ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2011 Mar; 124(6):845-50. PubMed ID: 21518590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a clinical prediction model for ischemic stroke recurrence after successful stent implantation in symptomatic intracranial atherosclerotic stenosis.
    Wang Y; Zhou Y; Hu H; Liu C; Wang P; Zhang L; Chu J; Lu Z; Guo Z; Jing W; Liu H
    J Clin Neurosci; 2024 May; 123():137-147. PubMed ID: 38574685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of high level of hs-CRP with in-stent restenosis: A case-control study.
    Baktashian M; Saffar Soflaei S; Kosari N; Salehi M; Khosravi A; Ahmadinejad M; Moohebati M; Ebrahimi M; Rahmani F; Khameneh-Bagheri R; Ahmadi M; Sadabadi F; Tayefi M; Bazhdanzadeh S; Ferns GA; Hashemi SM; Pasdar A; Ghayour-Mobarhan M
    Cardiovasc Revasc Med; 2019 Jul; 20(7):583-587. PubMed ID: 30232022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular treatment of symptomatic severe intracranial atherosclerotic stenosis with a novel intracranial dedicated drug-eluting stent: a more effective treatment approach.
    Ma L; Wang F; Feng H; Yan S; Xu JC; Cheng YS; Fang C
    Front Neurol; 2024; 15():1304524. PubMed ID: 38585365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated hs-CRP and Symptomatic Intracranial/Extracranial Artery Stenosis Predict Stroke Recurrence after Acute Ischemic Stroke or TIA.
    Li S; Jing J; Li J; Wang A; Meng X; Wang Y
    J Atheroscler Thromb; 2023 Jun; 30(6):601-610. PubMed ID: 35934783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Hs-CRP Levels Are Associated with Higher Risk of Intracranial Arterial Stenosis.
    Su BJ; Dong Y; Tan CC; Hou XH; Xu W; Sun FR; Cui M; Dong Q; Tan L; Yu JT
    Neurotox Res; 2020 Feb; 37(2):425-432. PubMed ID: 31691187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a Drug-Eluting Stent vs. Bare Metal Stent for the Treatment of Symptomatic Intracranial and Vertebral Artery Stenosis.
    Si JH; Ma N; Gao F; Mo DP; Luo G; Miao ZR
    Front Neurol; 2022; 13():854226. PubMed ID: 35911924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement.
    Rittersma SZ; de Winter RJ; Koch KT; Schotborgh CE; Bax M; Heyde GS; van Straalen JP; Mulder KJ; Tijssen JG; Sanders GT; Piek JJ
    Clin Chem; 2004 Sep; 50(9):1589-96. PubMed ID: 15205368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
    Zeng M; Yan X; Wu W
    BMC Cardiovasc Disord; 2021 Sep; 21(1):446. PubMed ID: 34535088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of soft plaque and elevated preprocedural high-sensitivity C-reactive protein levels to incidence of in-stent restenosis after successful coronary artery stenting.
    Hong YJ; Jeong MH; Lim SY; Lee SR; Hong SN; Kim KH; Sohn IS; Park HW; Kim JH; Kim W; Ahn Y; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2006 Aug; 98(3):341-5. PubMed ID: 16860020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up.
    Cheng G; Chang FJ; Wang Y; You PH; Chen HC; Han WQ; Wang JW; Zhong NE; Min ZQ
    Med Sci Monit; 2019 Jan; 25():240-247. PubMed ID: 30617247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wingspan stenting for intracranial atherosclerotic stenosis: clinical outcomes and risk factors for in-stent restenosis.
    Shin YS; Kim BM; Suh SH; Jeon P; Kim DJ; Kim DI; Kim BS; Kim KH; Heo JH; Nam HS; Kim YD
    Neurosurgery; 2013 Apr; 72(4):596-604; discussion 604. PubMed ID: 23277374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact factors of in-stent restenosis following successful stent implantation for acquired severe pulmonary vein stenosis post atrial fibrillation ablation].
    Li YJ; Pan X; Wang C; Ma L; He B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 May; 48(5):373-377. PubMed ID: 32450653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.